SCH772984
SCH772984 is a novel, specific inhibitor of ERK1/2 with IC50 values of 4 nM and 1 nM in cell-free assay, respectively, And show robust efficacy in RAS- or BRAF-mutant cancer cells.
Inquire / Order:
manager@chemfaces.com
Technical Inquiries:
service@chemfaces.com
Tel:
+86-27-84237783
Fax:
+86-27-84254680
Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to
24 months(2-8C).
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com
The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
Front Immunol.2023, 14:1240800.
Vet World.2023, 16(3):618-630.
J Appl Toxicol.2024, jat.4615.
Molecules.2024, 29(11):2626.
Pharmaceuticals (Basel).2024, 17(3):341.
Int J Mol Sci.2021, 22(16):8641.
Bull. Natl. Mus. Nat. Sci.2021, 47(2),109-114.
Braz J Biol.2023, 82:e266573.
Antioxidants (Basel).2023, 13(1):12.
J Korean Soc Food Sci Nutr2023, 52(12):1248-1255
Related and Featured Products
Cancer Discov,2013 Jul;3(7):742-50.
Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors.[Pubmed:
23614898]
Cell lines:BRAF-mutant or RAS-mutant tumor lines
Concentrations: ~10 μM
Incubation Time: 5 days
Method:
Cell proliferation experiments are performed in a 96-well format (six replicates), and cells are plated at 4,000/well density. At 24 h after cell seeding, cells are treated with DMSO or 9 point IC50 dilution (0.001-10 μM) at 1% DMSO final for all concentrations. Viability is assayed on 5 days after dosing using ViaLight luminescence kit following the manufacturer’s recommendations. For cell line panel viability assay, cells are treated with SCH772984 for 4 days and assayed by CellTiterGlo luminescent cell viability assay.
Cancer Discov,2013 Jul;3(7):742-50.
Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors.[Pubmed:
23614898]
Animal Models:Nude mice
Dosages: 12.5 mg/kg, 25 mg/kg, 50 mg/kg
Administration: i.p.
